Keywords: tg, halts, tgaac94, trial, after, death, patient

TG halts tgAAC94 trial after death of patient

Article | 06 August 2007

Print This

Seattle, USA-based biotechnology firm Targeted Genetics has reported the death of a trial volunteer who suffered a serious adverse event ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in